Theralase Technologies Inc
F:TTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Theralase Technologies Inc
F:TTX
|
CA |
|
D
|
Dometic Group AB (publ)
F:D00
|
SE |
|
O
|
Orron Energy AB
SWB:LYV
|
SE |
|
R
|
Riber SA
SWB:RI7
|
FR |
|
M
|
MPC Muenchmeyer Petersen Capital AG
SWB:MPCK
|
DE |
|
Takeuchi Mfg Co Ltd
OTC:TKUGF
|
JP |
|
J
|
JM AB
F:JMM
|
SE |
|
B
|
Brother Industries Ltd
OTC:BRTHY
|
JP |
|
Blue Foundry Bancorp
F:5P8
|
US |
|
I
|
Intercorp Financial Services Inc
F:9IFA
|
PE |
|
A
|
Asseco Poland SA
XMUN:SFB1
|
PL |
|
U
|
US Ecology Inc
F:3ER
|
US |
|
L
|
Li3 Lithium Corp
F:WD9
|
CA |
|
Nykode Therapeutics ASA
F:5VB
|
NO |
|
S
|
Saras SpA
XMUN:S7A
|
IT |
Bankruptcy Probability
Theralase Technologies Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Theralase Technologies Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
|
Theralase Technologies Inc
XTSX:TLT
|
49.8m CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
197.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
132.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
125.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
118.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
71.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
45B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
51.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
51.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
43.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
34B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Theralase Technologies Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Theralase Technologies Inc has total debt of 349.3k CAD. This includes both short-term (255.9k CAD) and long-term (93.4k CAD) debt.
You can find a full breakdown on its Balance Sheet.
